FDA Inspection 1087576 — OSRX Inc.
The FDA completed an inspection of OSRX Inc. on April 25, 2019 in Missoula, MT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Missoula, MT (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 18968 | FDCA 501(a)(2)(A) | Inadequate filter, final product sterilization |